The cost to global health of drug company profits.
Publication
, Journal Article
MacDonald, R; Yamey, G
Published in: The Western journal of medicine
May 2001
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
The Western journal of medicine
DOI
EISSN
1476-2978
ISSN
0093-0415
Publication Date
May 2001
Volume
174
Issue
5
Start / End Page
302 / 303
Related Subject Headings
- Risk Assessment
- Male
- Humans
- Global Health
- Female
- Ethics
- Drug Industry
Citation
APA
Chicago
ICMJE
MLA
NLM
MacDonald, R., & Yamey, G. (2001). The cost to global health of drug company profits. The Western Journal of Medicine, 174(5), 302–303. https://doi.org/10.1136/ewjm.174.5.302
MacDonald, R., and G. Yamey. “The cost to global health of drug company profits.” The Western Journal of Medicine 174, no. 5 (May 2001): 302–3. https://doi.org/10.1136/ewjm.174.5.302.
MacDonald R, Yamey G. The cost to global health of drug company profits. The Western journal of medicine. 2001 May;174(5):302–3.
MacDonald, R., and G. Yamey. “The cost to global health of drug company profits.” The Western Journal of Medicine, vol. 174, no. 5, May 2001, pp. 302–03. Epmc, doi:10.1136/ewjm.174.5.302.
MacDonald R, Yamey G. The cost to global health of drug company profits. The Western journal of medicine. 2001 May;174(5):302–303.
Published In
The Western journal of medicine
DOI
EISSN
1476-2978
ISSN
0093-0415
Publication Date
May 2001
Volume
174
Issue
5
Start / End Page
302 / 303
Related Subject Headings
- Risk Assessment
- Male
- Humans
- Global Health
- Female
- Ethics
- Drug Industry